| Literature DB >> 34064555 |
Edyta B Hendiger1,2, Marcin Padzik1, Inés Sifaoui2, María Reyes-Batlle2, Atteneri López-Arencibia2, Diana Zyskowska1, Marta Grodzik3, Anna Pietruczuk-Padzik4, Jacek Hendiger5, Gabriela Olędzka1, Lidia Chomicz1, José E Piñero2, Jacob Lorenzo-Morales2.
Abstract
Acanthamoeba keratitis (AK), a severe sight-threatening corneal infection, has become a significant medical problem, especially among contact lens wearers. The disease manifests as eye pain, congestion, blurred vision, lachrymation, and ring-shaped infiltrates of the cornea, and can lead to permanent blindness. Inappropriate habits of contact lens users may result in an increased risk of AK infection. The anti-amoebic efficiency of popular multipurpose contact lens solutions is insufficient to reduce this risk. An effective and non-toxic therapy against AK has not yet been developed. The prevention of AK is crucial to reduce the number of AK infections. Nanoparticles are known to be active agents against bacteria, viruses, and fungi and were also recently tested against protozoa, including Acanthamoeba spp. In our previous studies, we proved the anti-amoebic and anti-adhesive activity of silver nanoparticles against Acanthamoeba castellanii. The aim of this study is to evaluate the activity, cytotoxicity, and anti-adhesive properties of silver nanoparticles conjugated with five commonly used multipurpose contact lens solutions against the Acanthamoeba castellanii NEFF strain. The obtained results show a significant increase in anti-amoebic activity, without increasing the overall cytotoxicity, of Solo Care Aqua and Opti Free conjugated with nanoparticles. The adhesion of Acanthamoeba trophozoites to the contact lens surface is also significantly reduced. We conclude that low concentrations of silver nanoparticles can be used as an ingredient in contact lens solutions to decrease the risk of Acanthamoeba keratitis infection.Entities:
Keywords: Acanthamoeba keratitis; contact lens solutions; contact lenses; silver nanoparticles
Year: 2021 PMID: 34064555 PMCID: PMC8151187 DOI: 10.3390/pathogens10050583
Source DB: PubMed Journal: Pathogens ISSN: 2076-0817
Figure 1Left: Activity of Acanthamoeba trophozoites evaluated by fluorescence after 3 h of incubation with Opti-Free (O-F) conjugated with AgNPs in different concentrations. Right: Activity of Acanthamoeba trophozoites evaluated by fluorescence after 4 h of incubation with Opti-Free (O-F) conjugated with AgNPs in different concentrations. The same letters on different bars indicate no statistical significance (homogenous groups). “0” refers to the activity of the pure contact lens solution.
Figure 2Acanthamoeba trophozoites after 4 h of incubation with (A) 25 ppm AgNPs conjugated with O-F, (B) O-F itself, and (C) peptone yeast glucose (PYG) medium.
Figure 3Left: Activity of Acanthamoeba trophozoites evaluated by fluorescence after 3 h of incubation with Solo Care Aqua (SCA) conjugated with AgNPs in different concentrations. Right: Activity of Acanthamoeba trophozoites evaluated by fluorescence after 4 h of incubation with Solo Care Aqua (SCA) conjugated with AgNPs in different concentrations. The same letters on different bars indicate no statistical significance (homogenous groups). “0” refers to the activity of the pure contact lens solution.
Figure 4Acanthamoeba trophozoites after 4 h of incubation with (A) 25 ppm AgNPs conjugated with SCA, (B) SCA itself, and (C) PYG medium.
Figure 5Left: Cytotoxicity on the macrophage cell line (J774A.1) evaluated by fluorescence after 3 h of incubation with Solo Care Aqua (SCA) conjugated with AgNPs in different concentrations. Right: Cytotoxicity on the macrophage cell line (J774A.1) evaluated by fluorescence after 4 h of incubation with Solo Care Aqua (SCA) conjugated with AgNPs in different concentrations. The same letters on different bars indicate no statistical significance (homogenous groups). “0” refers to the activity of the pure contact lens solution.
Figure 6Left: Cytotoxicity on the macrophage cell line (J774A.1) evaluated by fluorescence after 3 h of incubation with Opti-Free (O-F) conjugated with AgNPs in different concentrations. Right: Cytotoxicity on the macrophage cell line (J774A.1) evaluated by fluorescence after 4 h of incubation with Opti-Free (O-F) conjugated with AgNPs in different concentrations. The same letters on different bars indicate no statistical significance (homogenous groups). “0” refers to the activity of the pure contact lens solution.
Acanthamoeba castellanii results of the adhesion reduction (AR) to the contact lens surface.
| FDA 1 | FDA 2 | FDA 3 | FDA 4 | |
|---|---|---|---|---|
| SCA | 8.8 ± 4.2 | no activity | no activity | 63.5 ± 14.0 |
| SCA + 25 ppm AgNPs | 90.0 ± 2.2 | no activity | 51.6 ± 9.1 | 95.2 ± 1.5 |
| SCA + 12.5 ppm AgNPs | 74.4 ± 0.8 | no activity | 50.9 ± 6.2 | 93.1 ± 2.3 |
| SCA + 6.25 ppm AgNPs | 36.9 ± 0.4 | no activity | 21.1 ± 20.5 | 89.0 ± 2.4 |
| SCA + 3.125 ppm AgNPs | unreliable data | no activity | 37.9 ± 5.0 | 80.3 ± 6.1 |
| O-F | 13.2 ± 23.2 | unreliable data | no activity | no activity |
| O-F + 25 ppm AgNPs | 94.7 ± 3.7 | unreliable data | 95.3 ± 0.5 | 94.7 ± 0.7 |
| O-F + 12.5 ppm AgNPs | 91.9 ± 2.1 | unreliable data | 69.8 ± 2.9 | 82.2 ± 0.3 |
| O-F + 6.25 ppm AgNPs | 76.7 ± 3.3 | unreliable data | 55.6 ± 13.5 | 62.7 ± 0.7 |
| O-F + 3.125 ppm AgNPs | 56.4 ± 0.4 | unreliable data | 6.1 ± 55.8 | 55.7 ± 19.0 |
Figure 7Acnthamoeba castellanii visualized results of the adhesion reduction (AR) to FDA group 4 contact lenses’ surface after treatment with O-F conjugated with AgNPs. (A) Water control; (B) O-F control; (C) AgNPs at 3.125 ppm; (D) AgNPs at 6.25 ppm; (E) AgNPs at 12.5 ppm; (F) AgNPs at 25 ppm.
Figure 8Acnthamoeba castellanii visualized results of the adhesion reduction (AR) to FDA group 1 contact lenses’ surface after treatment with SCA conjugated with AgNPs. (A) Water control; (B) O-F control; (C) AgNPs at 3.125 ppm; (D) AgNPs at 6.25 ppm; (E) AgNPs at 12.5 ppm; (F) AgNPs at 25 ppm.
Ingredients of the multipurpose contact lens solutions and minimum disinfection times recommended by the manufacturers.
| Manufacturer | Solution | Ingredients | Minimum Disinfection Time (h) |
|---|---|---|---|
| Menicon | Solo Care Aqua (SCA) | Polyhexanide 0.0001%, Hydrolock (dexpanthenol, sorbitol), sodium phosphate, tromethamine, poloxamer 407, disodium edetate | 4 |
| Alcon | Opti Free (O-F) | TearGlyde (Tetronic 1304, nonanoyl ethylenediaminetriacetic acid), Polyquad (polyquaternium-1) 0.001%, Aldox (myristamidopropyl dimethylamine) 0.0005% | 6 |
| Bausch + Lomb | ReNu Multiplus (ReNu) | Hydranate (hydroxyalkylphosphonate) 0.03%, boric acid, edetate disodium, poloxamine 1%, sodium borate, sodium chloride, preserved with Dymed (polyaminopropyl biguanide 0.0001%) | 4 |
| B-Lens | B-Lens (BL) | Polyheksametylene biguanide (PHMB) 0.0001%, Pluronic F 1%, Panthenol 1.5%. | 4 |
| Best View | Best View (BV) | PHMB 0.0001%, Ethylenediaminetetraacetic acid (EDTA), 0.01%, Pluronic | 6 |
Characterization of the FDA types of the hydrogel contact lenses used in the study.
| Polymer | FDA Group | Water Content | Ionic | Silicon Content | Manufacturer |
|---|---|---|---|---|---|
| Senofilcon A | 1 | 38% | no | yes | ACUVUE oasys |
| Nelfilcon A | 2 | 69% | no | no | Dailies |
| Balafilcon A | 3 | 36% | yes | yes | Baush + Lomb PureVision |
| Methafilcon A | 4 | 55% | yes | no | FitView |